Farm Pride Foods Ltd (FRM)
Market Closed
ASX ASX Primary - Market Cap
- P/E Ratio
- Div Yield
55,909 Volume
0 Eps
Want to track FRM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
FRM pays dividends to its shareholders, with the most recent payment made on Sep 30, 1999. The next estimated payment will be in 30 Sep 1999 on Sep 30, 1999 for a total of A$0.01138.
The last earnings report, released on Feb 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0067%, based on the last three reports.
Farm Pride Foods Ltd has completed 2 stock splits, with the recent split occurring on Jan 03, 2023.
The company's stock is traded on one exchange.
Farm Pride Foods Ltd (FRM) FAQ
On which exchange is it traded?
Farm Pride Foods Ltd is listed on ASX.
What is its stock symbol?
The ticker symbol is FRM.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Farm Pride Foods Ltd ever had a stock split?
Farm Pride Foods Ltd had 2 splits and the recent split was on Jan 03, 2023.
Farm Pride Foods Ltd Profile
| Banks Industry | Financials Sector | Dr. Peter Laurence Molloy BSc, FAICD, MBA CEO | ASX Exchange | Q3734H101 CUSIP |
| AU Country | - Employees | 17 Sep 1999 Last Dividend | 3 Jan 2023 Last Split | - IPO Date |
Overview
Firebrick Pharma Limited, established in 2012 and headquartered in Melbourne, Australia, is a pharmaceutical company focused on the development and commercialization of innovative formulations of povidone iodine. Specializing in creating products that offer broad-spectrum antimicrobial properties, Firebrick Pharma has carved a niche in the healthcare sector with a strong emphasis on treating respiratory conditions like the common cold. Expanding its reach beyond Australia, the company also operates in the United States and Singapore, showcasing its global ambition and commitment to healthcare solutions.
Products and Services
- Nasodine Nasal Spray - A unique formulation developed as a broad-spectrum antimicrobial nasal spray aimed at treating the common cold. By utilizing the antiseptic properties of povidone iodine, Nasodine offers an innovative approach to cold prevention and treatment, distinguished by its efficacy in targeting a wide range of pathogens responsible for respiratory infections.
Contact Information
Address: 440 Collins Street, Melbourne, VIC, Australia, 3000
Phone: 1300 301 874
Website: https://www.firebrickpharma.com
